Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s health, today announced that W. Grant Stevens, MD, FACS, has been named chairman of the Company’s Aesthetic Advisory Board. Dr. Stevens is the founder and medical director of Marina Plastic Surgery and The Institute, a medical spa
TORONTO, ONTARIO and SMITHS FALLS, ONTARIO–(Marketwired – Jan. 30, 2017) – Mettrum Health Corp. (TSXV:MT.V) and Canopy Growth Corporation (TSX:CGC) (“Canopy Growth”, and together with Mettrum, the “Companies”) are pleased to announce that the Ontario Superior Court of Justice has issued a final order approving the proposed acquisition by Canopy
SMITHS FALLS and TORONTO, ON, Jan. 27, 2017 /CNW/ – Canopy Growth Corporation (“Canopy Growth”) (TSX: CGC) and Mettrum Health Corp. (TSXV:MT.V) (together, the “Companies”) are pleased to announce the successful results of the Special Meetings of Shareholders of Canopy Growth and Mettrum, held in Smiths Falls, Ontario and Toronto,
Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women’s health, today announced the company has received regulatory approvals from the Ministries of Health in Colombia and Costa Rica. In each country the Viveve® System is indicated for treatment of the vaginal introitus to improve sexual function after vaginal
Vifor Pharma and ChemoCentryx (Nasdaq:CCXI), announced today the expansion of their existing kidney health alliance to include the development and commercialization of CCX140, an orally-administered inhibitor of the chemokine receptor known as CCR2, for renal diseases.
MediWound announces that the United States Patent and Trademark Office (USPTO) has issued patent Number 9,511,126 with claims related to the Company’s proprietary injectable bromelain solution, MWPC003, for enzymatic treatment of connective tissue diseases.
Vericel Corporation today announced the pricing of its previously announced underwritten public offering of 6,200,000 shares of its common stock, offered at a price to the public of $2.75 per share.
GB Sciences is pleased to announce that its wholly-owned subsidiary, Growblox Life Sciences, LLC has licensed intellectual property from Makai Biotechnology, LLC.
Dimension Therapeutics today announced that the U.S. Food and Drug Administration (FDA) accepted Dimension’s investigational new drug (IND) application for DTX301 for the treatment of Ornithine Transcarbamylase (OTC) Deficiency.
CannaRoyalty (CSE:CRZ)(CSE:CRZ.CN) is pleased to announce today the commencement of trading of the company’s common shares on the Canadian Securities Exchange (the “CSE”), under the symbol “CRZ”.
“With the start of public trading, we are delighted to provide CannaRoyalty investors with access to high value assets that cover the full spectrum
“This agreement is a major step forward for CuMoCo and its shareholders. We welcome our new partner and look forward to creating substantial jobs and value for the economy of Idaho as we move our projects forward,” said Shaun Dykes, President and CEO of American CuMo Mining Corporation (TSXV:MLY,OTCPINK:MLYCF).
Appointment of Thierry Vergnol – President of Algold Mauritania SARL. and Vice-President Government, Community Relations & Security of Algold Resources Ltd.
Timmins Gold (TSX:TMM)(NYSE:TGD) is pleased to confirm closing of its previously announced bought deal offering of 36,400,000 units of the Company (the “Units”), at a price C$0.55 per Unit for gross proceeds to the Company of approximately C$20 million (the “Offering”).
The Units were issued in a public offering in all of
Dimension Therapeutics today announced that the European Medicines Agency Committee for Orphan Medicinal Products has issued a positive opinion recommending DTX401 for designation as an orphan medicinal product for the treatment of Glycogen Storage Disease Type Ia.
Falco Resources Ltd. (TSXV:FPC) – The company’s prospectus dated Nov. 15, 2016, was filed with and accepted by the TSX Venture Exchange, and filed with and receipted by the Alberta, Manitoba, British Columbia, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and Autorite des marches financiers du
Vancouver, British Columbia–(Newsfile Corp. – November 21, 2016) – American CuMo Mining Corporation (TSXV:MLY,OTCPINK:MLYCF) announces that its wholly-owned subsidiary, Idaho CuMo Mining Corporation (“Idaho CuMo”) executed an arm’s-length Limited Liability Company Agreement (the “LLC Agreement”) with Platinum Resources International Limited, a corporation existing under the laws of the British Virgin
Royal Philips, a leading health technology company, today announced the launch of the Philips IQon Spectral CT in Canada.